Get the Stockscreener App
2.34
1.27%
-0.03
After Hours:
2.30
-0.04
-1.71%
Kiora Pharmaceuticals Inc stock is traded at $2.34, with a volume of 29,866.
It is down -1.27% in the last 24 hours and down -14.91% over the past month.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
See More
Previous Close:
$2.37
Open:
$2.35
24h Volume:
29,866
Relative Volume:
0.55
Market Cap:
$8.03M
Revenue:
-
Net Income/Loss:
$2.81M
P/E Ratio:
-0.1631
EPS:
-14.3497
Net Cash Flow:
$7.14M
1W Performance:
-7.51%
1M Performance:
-14.91%
6M Performance:
-28.28%
1Y Performance:
-33.52%
1-Day Range:
$2.30
$2.41
1-Week Range:
$2.22
$2.5735
52-Week Range:
$2.21
$4.18
Kiora Pharmaceuticals Inc Stock (KPRX) Company Profile
Name
Kiora Pharmaceuticals Inc
Sector
Industry
Phone
858-224-9600
Address
169 SAXONY RD., ENCINITAS
Compare KPRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KPRX
Kiora Pharmaceuticals Inc
|
2.34 | 8.14M | 0 | 2.81M | 7.14M | -14.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
417.00 | 107.10B | 11.70B | 3.68B | 3.50B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
644.19 | 66.00B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.56 | 55.95B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
832.35 | 51.19B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.88 | 38.98B | 447.02M | -1.18B | -906.14M | -6.1812 |
Kiora Pharmaceuticals Inc Stock (KPRX) Latest News
Heatmap analysis for Kiora Pharmaceuticals Inc. and competitorsSwing Trade & Weekly High Conviction Ideas - newser.com
Can Kiora Pharmaceuticals Inc. stock resist market sell offsJuly 2025 Catalysts & Community Trade Idea Sharing Platform - newser.com
Published on: 2025-11-05 02:12:11 - newser.com
Chart based exit strategy for Kiora Pharmaceuticals Inc.Weekly Stock Report & Fast Moving Stock Watchlists - newser.com
Published on: 2025-11-05 00:24:52 - newser.com
How to build a dashboard for Kiora Pharmaceuticals Inc. stock2025 Historical Comparison & Precise Swing Trade Entry Alerts - newser.com
Tools to monitor Kiora Pharmaceuticals Inc. recovery probabilityWeekly Investment Report & Fast Entry Momentum Alerts - newser.com
Will Kiora Pharmaceuticals Inc. continue its uptrendMarket Sentiment Report & Safe Swing Trade Setups - newser.com
What candlestick patterns are forming on Kiora Pharmaceuticals Inc.Portfolio Gains Report & Step-by-Step Trade Execution Guides - newser.com
Eyes On KioraABACUS-2 And KLARITY Data Readouts Due In 2027 - RTTNews
Can Kiora Pharmaceuticals Inc. stock double in next 5 yearsJuly 2025 Momentum & Stepwise Entry/Exit Trade Alerts - newser.com
Real time breakdown of Kiora Pharmaceuticals Inc. stock performanceJuly 2025 Selloffs & Risk Controlled Daily Plans - newser.com
Can Kiora Pharmaceuticals Inc. (7EY) stock attract ESG investmentsAnalyst Upgrade & Expert Curated Trade Setups - newser.com
When is the best time to exit Kiora Pharmaceuticals Inc.2025 Price Targets & Reliable Breakout Stock Forecasts - newser.com
News impact scoring models applied to Kiora Pharmaceuticals Inc.Take Profit & Fast Entry High Yield Tips - newser.com
Can Kiora Pharmaceuticals Inc. stock sustain free cash flow growthWeekly Trend Report & Weekly Setup with ROI Potential - newser.com
Analyzing recovery setups for Kiora Pharmaceuticals Inc. investors2025 Analyst Calls & AI Driven Price Predictions - newser.com
Working capital per share of Kiora Pharmaceuticals, Inc. – MUN:7EY - TradingView
Kiora Pharmaceuticals’ KIO-104: A Promising Treatment for Macular Edema? - MSN
Is Kiora Pharmaceuticals Inc. stock supported by strong cash flowsPrice Action & AI Driven Stock Movement Reports - newser.com
Using data filters to optimize entry into Kiora Pharmaceuticals Inc.Quarterly Earnings Summary & Free Accurate Trade Setup Notifications - newser.com
Is it time to cut losses on Kiora Pharmaceuticals Inc.Quarterly Market Review & Stepwise Trade Execution Plans - newser.com
Why global investors buy Kiora Pharmaceuticals Inc. (7EY) stockJuly 2025 Momentum & Expert Curated Trade Setup Alerts - newser.com
How buyback programs support Kiora Pharmaceuticals Inc. (7EY) stockCPI Data & Stock Market Timing Techniques - newser.com
Will Kiora Pharmaceuticals Inc. stock benefit from infrastructure spendingJuly 2025 Summary & Scalable Portfolio Growth Methods - newser.com
Will Kiora Pharmaceuticals Inc. (7EY) stock benefit from commodity supercyclePortfolio Value Summary & Daily Volume Surge Signals - newser.com
Intraday pattern recognizer results for Kiora Pharmaceuticals Inc.Bear Alert & AI Enhanced Trade Execution Alerts - newser.com
Can Kiora Pharmaceuticals Inc. rally from current levelsShare Buyback & Real-Time Buy Signal Notifications - newser.com
Will Kiora Pharmaceuticals Inc. stock deliver consistent dividends2025 EndofYear Setup & Long Hold Capital Preservation Tips - newser.com
How to track smart money flows in Kiora Pharmaceuticals Inc.July 2025 Sentiment & Risk Controlled Stock Pick Alerts - newser.com
Kiora Pharmaceuticals Inc Stock (KPRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
6.82%
1.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):